APA (7th ed.) Citation

Tielen, R., Verhoef, C., van Coevorden, F., Gelderblom, H., Sleijfer, S., Hartgrink, H. H., . . . de Wilt, J. H. W. (2012). Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: Is it worthwhile? World Journal of Surgical Oncology, 10(1), 111. https://doi.org/10.1186/1477-7819-10-111

Chicago Style (17th ed.) Citation

Tielen, Ronald, Cornelis Verhoef, Frits van Coevorden, Hans Gelderblom, Stefan Sleijfer, Henk H. Hartgrink, Johannes J. Bonenkamp, Winette T. van der Graaf, and Johannes H. W. de Wilt. "Surgery After Treatment with Imatinib And/or Sunitinib in Patients with Metastasized Gastrointestinal Stromal Tumors: Is It Worthwhile?" World Journal of Surgical Oncology 10, no. 1 (2012): 111. https://doi.org/10.1186/1477-7819-10-111.

MLA (9th ed.) Citation

Tielen, Ronald, et al. "Surgery After Treatment with Imatinib And/or Sunitinib in Patients with Metastasized Gastrointestinal Stromal Tumors: Is It Worthwhile?" World Journal of Surgical Oncology, vol. 10, no. 1, 2012, p. 111, https://doi.org/10.1186/1477-7819-10-111.